Arthritis care & research · 2026
Exploring the Role of Community Pharmacy in the Management of Osteoarthritis: Surveys and Interviews With People With Osteoarthritis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Simkins Joanna, Babatunde Opeyemi O, Holden Melanie A, O'Brien Nicola, Nicholls Elaine, Long Angela, Dziedzic Krysia, Chudyk Adrian, Todd Adam, Walker Christine, Webb David, Stanford Colin, Cottrell Elizabeth, Healey Emma L, Cork Tania, Mallen Christian, White Simon
Аннотация
OBJECTIVE: Osteoarthritis (OA) is a leading cause of joint pain, and people often self-manage their symptoms before seeking support. Community pharmacies are accessible and well placed to support people with OA using pharmacological and nonpharmacological approaches. Current policy recommends that pharmacies should be integrated into long-term condition management pathways. This study aimed to explore the experiences of people with OA engaging with community pharmacy staff for their joint problems and their views about an extended community pharmacy role for OA.
METHODS: A multimethod study gathered surveys of people with OA who were recruited through general practices in two geographic areas of the United Kingdom, followed by qualitative interviews with respondents who consented to further contact. Survey data underwent descriptive statistical analysis, and qualitative data were analyzed using reflexive thematic analysis, mapped to the Theoretical Domains Framework.
RESULTS: In 450 survey responses and 18 interviews, people with OA reported that current community pharmacy OA care focused on advice about medicine and sometimes included self-care advice. There was support for an extended role for OA management in community pharmacy that focused on explaining the joint problem and its treatment, medicine optimization, and support for self-care (including exercise and weight management). However, there was uncertainty about whether community pharmacists should diagnose OA. A reported key facilitator to this extended role was pharmacy staff training, and barriers included high workloads and limited access to medical records.
CONCLUSION: Current community pharmacy care for people with OA could be extended and include a greater focus on supported self-care.
METHODS: A multimethod study gathered surveys of people with OA who were recruited through general practices in two geographic areas of the United Kingdom, followed by qualitative interviews with respondents who consented to further contact. Survey data underwent descriptive statistical analysis, and qualitative data were analyzed using reflexive thematic analysis, mapped to the Theoretical Domains Framework.
RESULTS: In 450 survey responses and 18 interviews, people with OA reported that current community pharmacy OA care focused on advice about medicine and sometimes included self-care advice. There was support for an extended role for OA management in community pharmacy that focused on explaining the joint problem and its treatment, medicine optimization, and support for self-care (including exercise and weight management). However, there was uncertainty about whether community pharmacists should diagnose OA. A reported key facilitator to this extended role was pharmacy staff training, and barriers included high workloads and limited access to medical records.
CONCLUSION: Current community pharmacy care for people with OA could be extended and include a greater focus on supported self-care.